Glioblastoma (GBM) is the most belligerent and frequent brain tumor in adults. Research
over the past two decades has provided increased knowledge of the genomic and molecular …

Background: Allogeneic hematopoietic cell transplantation is indicated for refractory
hematologic cancer and some nonmalignant disorders. Survival is limited by recurrent …

We performed a study to find out how advances in modern medicine have improved the
mortality risk of allogeneic stem cell transplantation. We analyzed major transplantation …

Bacterial bloodstream infections (BSI) cause significant transplant-related morbidity and
mortality following allogeneic hematopoietic cell transplantation (allo-HCT). This manuscript …

Although transplant practices have changed over the last decades, no information is
available on trends in incidence and outcome of chronic graft-versus-host disease (cGVHD) …

Refractory chronic graft-versus-host disease (cGVHD) is a significant complication resulting
from allogeneic hematopoietic stem cell transplantation (HSCT). Mesenchymal stromal cells …

Purpose Over the past four decades, allogeneic hematopoietic cell transplantation (alloHCT)
has evolved as a curative modality for patients with hematologic diseases. This study …

Purpose To investigate the impact of prior-to-transplantation azacitidine (AZA) on patient
outcome after allogeneic stem-cell transplantation (alloSCT) for myelodysplastic syndrome …

Allogeneic hematopoietic stem cell transplantation is a successful treatment for hematologic
malignancies and a variety of genetic and metabolic disorders. In the period following stem …

Hematopoietic stem cell transplantation (HSCT) has improved over the last few decades.
However, viral infections are often refractory to pharmacologic treatment and require …